by Craig Klugman, Ph.D. One of the changes that the Trump administration tried to make to the Affordable Care Act was to eliminate the requirementthat employer insurance plans cover the full cost of contraception. The new rules would have allowed businesses and nonprofits a religious and moral exemption from providing such coverage beginning this past Monday. Under the Obama administration, the Courts carved out exemptions for businesses that were religious in nature or that were privately run by a family of faith (see Little Sisters v.…
Read More →
by Craig Klugman, Ph.D. This Spring Quarter I had the honor of creating and teaching a new course at my university: HLTH 341 Death & Dying. Most readers of this blog in bioethics probably work in the medical school environment. When I taught in a medical school we provided lessons and experiences in giving bad news and hospice. We may have even taught briefly on the diagnostic tools to diagnose death.…
Read More →
#Bioethics News: The #flu season is going strong - about 6 - 7 million people in the US have come down with the illness so far, with half of them sick enough to see doctors, according to estimates released on Friday by the @CDCgov https://t.co/dh5hDQGVZ2
#Bioethics News: Settling allegations of discrimination filed by the Massachusetts attorney general’s office, Mutual of Omaha has agreed not to deny insurance to people who use medications to prevent H.I.V. infection https://t.co/VfKMpyGhmH
Our first OPC call for the year posted this week -- proposals due Jan 28th!
"Exploring Understanding of “Understanding”: The Paradigm Case of Biobank Consent Comprehension" & "Ethical Criteria for Health-Promoting Nudges: A Case-by-Case Analysis"
https://t.co/HZ69REZm7h
#Bioethics News: The #governmentshutdown has halted some of the federal government’s most important public health activities, power plants, oil refineries, water treatment plants, and thousands of other industrial sites for pollution violations. https://t.co/gi46MpEASg
#Bioethics News: The medical market has expanded substantially, with spending increasing from $17.7 to $29.9 billion, with direct-to-consumer advertising for prescription drugs and health services accounting for the most rapid growth https://t.co/rFR0gR6FBb
